Experimental & Molecular Medicine, 2023 · DOI: https://doi.org/10.1038/s12276-023-01003-2 · Published: June 1, 2023
Spinal cord injuries often lead to lasting sensory, motor, and autonomic disabilities. Currently, there's no standard medical treatment to reverse this damage. This study explores using induced neural stem cells (iNSCs) made from human urine cells to help spinal cord injury recovery in rats. The findings suggest that iNSCs could be a valuable tool for disease modeling and a potential source of personalized cells for nerve regeneration in spinal cord disorders.
iNSCs derived from patient urine cells can be used for autologous transplantation, reducing the risk of immune rejection.
iNSCs provide a valuable tool for studying the mechanisms of spinal cord injury and developing new therapeutic strategies.
iNSCs offer a safe and effective alternative to traditional stem cell sources, such as embryonic stem cells, for neural regeneration.